Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Feehally

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Kidney International Reports|February 14, 2022
Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy CohortSuceena Alexander, Santosh Varughese, Rajanbabu Franklin, et al.
JAMA|April 22, 2017
Assessment of Global Kidney Health Care StatusAminu K Bello, Adeera Levin, Marcello Tonelli, et al.
Kidney International|August 24, 2020
Disparities in end-stage kidney disease care for children: a global surveyRowena Lalji, Anna Francis, Germaine Wong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2009
Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patientsTanqi Lou, Jun Zhang, Daniel P Gale, et al.
Journal of the American Society of Nephrology : JASN|July 3, 2010
HLA has strongest association with IgA nephropathy in genome-wide analysisJohn Feehally, Martin Farrall, Anne Boland, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Lancet (London, England)|April 18, 2016
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional studyRavindra L Mehta, Emmanuel A Burdmann, Jorge Cerdá, et al.
European Journal of Applied Physiology|April 18, 2013
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expressionEmma L Watson, George C Kosmadakis, Alice C Smith, et al.
Clinical Nephrology|August 10, 2019
Kidney care in low- and middle-income countriesBilal Qarni, Mohamed A Osman, Adeera Levin, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2016
A Multicenter Study of the Predictive Value of Crescents in IgA NephropathyMark Haas, Jacobien C Verhave, Zhi-Hong Liu, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Kidney International Reports|February 14, 2022
Three-Year Clinical Outcomes of the First South Asian Prospective Longitudinal Observational IgA Nephropathy CohortSuceena Alexander, Santosh Varughese, Rajanbabu Franklin, et al.
JAMA|April 22, 2017
Assessment of Global Kidney Health Care StatusAminu K Bello, Adeera Levin, Marcello Tonelli, et al.
Kidney International|August 24, 2020
Disparities in end-stage kidney disease care for children: a global surveyRowena Lalji, Anna Francis, Germaine Wong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 25, 2009
Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patientsTanqi Lou, Jun Zhang, Daniel P Gale, et al.
Journal of the American Society of Nephrology : JASN|July 3, 2010
HLA has strongest association with IgA nephropathy in genome-wide analysisJohn Feehally, Martin Farrall, Anne Boland, et al.
Lancet (London, England)|April 2, 2017
Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trialBengt C Fellström, Jonathan Barratt, Heather Cook, et al.
Lancet (London, England)|April 18, 2016
Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: a multinational cross-sectional studyRavindra L Mehta, Emmanuel A Burdmann, Jorge Cerdá, et al.
European Journal of Applied Physiology|April 18, 2013
Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expressionEmma L Watson, George C Kosmadakis, Alice C Smith, et al.
Clinical Nephrology|August 10, 2019
Kidney care in low- and middle-income countriesBilal Qarni, Mohamed A Osman, Adeera Levin, et al.
Journal of the American Society of Nephrology : JASN|September 11, 2016
A Multicenter Study of the Predictive Value of Crescents in IgA NephropathyMark Haas, Jacobien C Verhave, Zhi-Hong Liu, et al.
Pageof 14